1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. LAB ON CHIPS MARKET BY PRODUCT
5.1. Introduction
5.2. Reagents and Consumables
5.3. Instruments
5.4. Software and Services
6. LAB ON CHIPS MARKET BY TECHNOLOGY
6.1. Introduction
6.2. Microarray
6.3. Microfluidics
6.4. Tissue Biochips
7. LAB ON CHIPS MARKET BY APPLICATION
7.1. Introduction
7.2. Genomics and Proteomics
7.3. Diagnostics
7.4. Others
8. LAB ON CHIPS MARKET BY END-USERS
8.1. Introduction
8.2. Hospitals and Clinics
8.3. Diagnostic Centers
8.4. Academic and Research Institutes
8.5. Others
9. LAB ON CHIPS MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. United States
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Spain
9.4.5. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. India
9.6.3. Japan
9.6.4. South Korea
9.6.5. Indonesia
9.6.6. Thailand
9.6.7. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Abbott Laboratories
11.2. F. Hoffmann-La Roche Ltd.
11.3. Siemens AG
11.4. Vital Diagnostics
11.5. Perkin Elmer
11.6. Lexinnova
11.7. Fluidigm
11.8. Danaher
11.9. Horiba
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations LIST OF FIGURESLIST OF TABLES